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Abstract
Prime aim of periodontal therapy is to set up a state of periodontal health with pocket 
elimination and attachment level gain, preferably by periodontal regeneration. Various 
tools/techniques have been proposed for this purpose. But, the quest still continues. 
In this context, the periosteum offers an attractive option for periodontal regeneration. 
The rationale for the use of periosteum lies in its anatomy and its physiologic functions 
during normalcy. Periosteum contains the desired stem cells and progenitor cells that are 
capable to produce periodontal tissues. Periosteum has high vasculo-proliferative and 
neuro-trophic activities. In addition, it is easier for the dentist to harvest the periosteum 
for clinical use. It can be harvested from adjacent to the surgery site in sufficient amounts. 
Even though it has many advantages, there is only limited research for exploiting the 
regenerative potential of periosteum for periodontal regeneration so far. Conversely, in 
the medical field, the periosteum is extensively used and proved to be promising. Hence, 
the aim of this paper is to discuss the regenerative potential of periosteum and various 
available tools and techniques to harness it for periodontal regeneration.
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Introduction
A plethora of research has been done in the past and even 
today the search for the “holy grail” of periodontal regeneration 
continues. Many regenerative approaches have been applied in an 
attempt to regenerate the lost periodontium with varying degrees 
of success.[1-3] These approaches include surgical placement of 
bone grafts or biologic agents (growth factors or enamel matrix 
derivatives) or their combination with or without a barrier 
membrane or tissue engineering approaches including stem cell 
research or other pharmacological agents. While the notable 
regenerative ability of the periosteum was documented in reports 
more than a century ago, only in the past decade scientists have 
carried out mechanistic examinations of periosteum’s regenerative 
potential. As of now, in the regenerative armamentarium of 
periodontology the periosteum has not got its deserved place.
Periosteum: Rationale for Its Use
Anatomy
From a structural outlook, periosteum is a composite 
biomaterial,[4] enveloping external surfaces of all the 
bones except in the areas of bone articulations and tendon 
attachments.[5] Periosteum is composed of three zones. 
Zone 1, also known as the cambium layer (closest to the 
bone) basically contains osteoblasts, osteoblast progenitor 
cells, and multipotent stem cells. Zone-2, also known as matrix 
layer basically contains fibroblasts, fibroblast progenitor cells, 
and dense vascular plexus. It is because of this matrix layer 
of the periosteum is highly vascular. Zone-3, also known as 
collagenous layer is the outermost layer of the periosteum, and 
it basically contains dense collagen fibers. Zone-2 and Zone-3 
are together known as fibrous layer. So in broader terms, the 
periosteum consists of two main layers, an inner cambium layer 
and an outer fibrous layer [Figure 1].[4,6,7] More than 90% of the 
cells in periosteum are fibroblastic in appearance. A prominent 
subpopulation of these cells has been identified as mesenchymal 
stem cells (MSCs) and progenitor cells.[8-10] However, the cell 
population of periosteum is diverse, potentially containing 
fibroblasts, fibroblast progenitor cells, osteoblasts, osteoblast 
progenitor cells, multipotent stem cells, pericytes.[6,11,12] It has 
been found that the periosteal stem cells and progenitor cells 
can differentiate into osteoblasts, fibroblasts, chondroblasts, 
adipocytes, and skeletal myocytes.[13]
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A unique property of these periosteal stem cells and 
progenitor cells is that in all age groups, they retain their ability 
of differentiation into a variety of cell lineages. However, it has 
been found that their capacity to differentiate in the direction of 
chondrogenic and adipogenic lineages reduces with age.[8,14,15] 
Pericytes have also been recognized as a distinct cell population 
in periosteum. They may have a function of re-vascularization 
and promotion of bone formation, but their role in periosteal 
bone formation is deemed minimal at present.[16]
Physiologic functions of periosteum in normalcy
In a fully developed state of the alveolar processes, periosteum 
serves several important functions: (1) It forms a variably 
rigid attachment for gingiva to bone because of its density 
and numerous fibrous insertions into bone. It also provides 
attachment linkage of the alveolar mucosa essentially to cortical 
bone of alveolar processes and jaws. These do not appear to 
be as tenacious as seen in case of attached gingiva to subjacent 
bone. The Sharpey’s fiber insertions here appear to be frailer, to 
be fewer with greater spacing over the cortical surface and have 
shallower penetration into bony cortex, (2) it carries principle 
vascular supply and lymphatic drainage for alveolar mucosa and 
gingiva. Additionally, it contributes to the vascularization of the 
adjacent bone, joining with branches of interseptal vessels to 
provide liberal blood supply to cancellous bone. Many of blood 
vessels coursing from periosteum to cortical bone are of minute 
caliber. They arise from an extensive and delicate vascular plexus 
located in the matrix layer of the periosteum and enter bone’s 
haversian canals directly joining with an elaborate microvascular 
arcade within cortical bone. Fluids also diffuse from periosteum’s 
extravascular connective tissue, as a transudate into bone, 
principally into and through a canalicular maze. In this manner, 
bone matrix is hydrated, mineral is added to and withdrawn 
homeostatically within bone, and osteocytes receive nutrients 
and release wastes. When osseous septa are thin and largely or 
completely composed of compact bone, the periosteal blood 
supply may constitute the principle one to the septum, (3) it 
contains prominent neural fibers, generally myelinated that 
liberally arborate into gingiva, mucosa, bone marrow and 
periosteum itself, (4) periosteum responds, generally in an 
appositional manner by osteogenesis and fibrogenesis through 
its multipotent stem cells in the inner cambium layer, to 
exigencies derived from overlying gingiva and mucosa. Thus, the 
inflammatory response in marginal gingiva is usually contained 
and restricted from progress through attached gingiva to the 
alveolar bone by the capacity of periosteum to repair in the face 
of irritation.
Despite its routine performance of these essential functions, 
periosteum is a “sleeping giant” only mildly stirred on a 
generative level by functional stimuli and gingival inflammatory 
processes. When surgical injury assails periosteum, it quickly 
springs to action, both appositionally and resorptively. In 
repair of periodontal wounds, the periosteum has a marked 
capacity for the following: (1) Multipotent stem cells in 
periosteum differentiate into osteogenic and fibrogenic cell 
lineages, (2) secretion of protein-polysaccharide complexes 
of the matrices of connective tissue, bone and blood vessels, 
(3) endothelial proliferation and the formation of new blood 
and lymphatic vessels, (4) after both partial-thickness and full-
thickness flap surgery periosteum responds by providing literally 
a “river of regenerative tissues” moving centripetally into the 
wound, (5) periosteum’s vasculature responds rheologically 
and by dilatation and permeability to provide hydration and 
nutritive materials to adjacent tissues and itself in the healing 
process. This is especially apparent in the sustenance of free 
gingival autografts and partial-thickness pedicle grafts that are 
largely or completely dependent on periosteum of the recipient 
site during the 1st week after grafting. Periosteal vessels serve as 
progenitors for new blood vessels required to link to those of 
the graft. A comparable lymphatic anastomoses occur, assisting 
substantially in removing exudate and cellular and other debris 
from the graft, (6) periosteum is a “springboard for nerve 
regeneration” into overlying gingiva, mucosa, or graft and into 
subjacent bone.
It has been noted that the periosteum, in particular, the inner, 
relatively quiescent cambium layer is stimulated to osteogenic, 
fibrogenic, vasculo-proliferative, and neuro-trophic activities 
by surgical trauma.[17] Since, periosteum offers a rich source of 
stem cells and progenitor cells, it has high vasculo-proliferative 
and neuro-trophic activities, and therefore, the regenerative 
potential of periosteum is enormous and should be harnessed 
for periodontal regeneration.
Harnessing the regenerative potential of periosteum
Remarkably, Duhamel can be regarded as the first researcher 
to study the osteogenic capacity of periosteum. He observed 
that agitation of the periosteum results in the formation of 
new bone.[18] More than a century later, Ollier found that 
the periosteal tissue when transplanted was able to form new 
Figure 1: Schematic presentation of three discrete zones of 
periosteum, (Adapted from reference no. 4: Chang H, Knothe 
Tate ML. Concise review: The periosteum: Tapping into a reservoir 
of clinically useful progenitor cells. Stem Cells Transl Med 
2012;1:480‑91)
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bone de‑novo.[19] One of the oldest experimental reports to 
demonstrate periosteum’s osteogenic capability was by Urist and 
Mclean. They transplanted periosteum to the anterior chamber 
of the eye in rat and reported that periosteum formed bone.[20] 
Melcher reported the formation of new bone in parietal bone 
defects in rats and was laid down by periosteum that was neither 
previously elevated nor disturbed.[21] Since then a number of 
experiments were attempted to “tap” the periosteum for tissue 
reconstruction with some attention in the field of dentistry also.
The necessity of a graft, which has its own vascular supply, and 
can be acquired in adequate amounts from adjacent to the defect 
site and has a capacity for providing periodontal regeneration, is yet 
to be fulfilled. In this context, the periosteum can prove to be a very 
close option. In addition, recently the periosteal cells have been 
found to produce vascular endothelial growth factor that helps in 
angiogenesis and wound healing [Figure 2].[22] The application 
of periosteum in periodontology is not so new and started with 
the researches in which the periosteum harvested from the palate 
was used as a barrier membrane to successfully treat furcation 
and intrabony defects.[23-25] Following this many techniques were 
introduced and attempted to take the advantage of periosteum’s 
regenerative potential for achieving periodontal regeneration.
Gaggl et al. proposed a periosteum eversion technique 
or perioplasty to cover the denuded roots. Patients with 
severe gingival recessions were successfully treated with this 
technique. The technique involves the reflection, eversion and 
coronal repositioning of periosteum from a full-thickness flap 
that is then placed over the denuded roots. The basis of tissue 
regeneration here is same as the conventional connective tissue 
graft.[26] A case series describes the successful treatment of severe 
gingival recessions with this technique.[27] Both the case series 
concluded that the periosteum eversion technique is suitable for 
the treatment of gingival recessions with a clear improvement 
in aesthetics.[26,27] Further studies are required to assess the 
effectiveness of the technique.
Steiner et al. introduced an inverted periosteal graft (IPG) 
technique. In the IPG, the normal anatomy of the periosteum is 
reversed or inverted i.e. the cambium layer (containing osteoblasts, 
osteoblast progenitor cells and multipotent stem cells) cover the 
fibrous layer (containing fibroblasts, fibroblast progenitor cells) 
which is placed immediately adjacent to the root surface. The cells 
having capability to produce cementum and periodontal ligament 
(i.e., fibroblasts, fibroblast progenitor cells) are the immediate 
cells put forward to the root surface, while osteoblasts, osteoblast 
progenitor cells and multipotent stem cells lie immediately outside 
the fibroblasts and fibroblast progenitor cells and produce the 
osseous counterpart. Thus, IPG seats the appropriate cells in the 
correct site for the periodontal regeneration.
There are two different techniques of IPG. One technique is 
to reflect a partial-thickness flap, leaving the periosteum on bone 
from which it is reflected, inverted, coronally advanced and placed 
over the periodontal defect. The second technique involves the 
reflection of full-thickness flap, lifting the periosteum off the flap, 
inverting and coronally advancing it followed by placing over the 
defects. It is clinician’s decision to opt any of the two techniques 
because both the techniques achieve the same objective.[28]
Gamal and Mailhot illustrated a marginal periosteal 
pedicle (MPP) graft to be used as a biologic barrier membrane 
for the treatment of deep angular 2- and 3- wall infrabony 
defects. They reported a significant improvement in clinical and 
radiographic parameters of deep infrabony defects. MPP graft 
consists of a facial partial-thickness and a lingual full-thickness 
flap followed by the creation of a facial marginal periosteal strip 
adjacent to the defect. Periosteum is then separated laterally on 
the facial aspect, keeping it attached to its base to be used as a 
pedicled biologic barrier membrane.[29,30] One study reported 
significant improvements in clinical and radiographic parameters 
for localized two-wall intrabony defects employing MPP graft 
with alloplasts.[31] Further research is needed to evaluate the 
effectiveness of MPP grafts as autogenous barrier membranes.
Tissue engineering is a new outlook for tissue regeneration 
by utilizing appropriate cells, bioactive signaling molecules and 
a scaffold (which is made up of a bio-degradable material either 
natural or synthetic.[32] Stem cells are being employed clinically 
for the regeneration of lost or missing tissues re-establishing 
natural form and function in many disciplines of medicine and 
dentistry. MSCs are simply cultured, multipotent, immune-
privileged cells, making them perfect candidate option for tissue 
engineering.[33,34] A huge body of literature describes the use of 
MSCs in regeneration of tissues. Many sources of MSCs have 
been identified, i.e., bone marrow, adipose tissue, umbilical 
tissue, muscle, periosteum etc. Bone marrow is the most widely 
used source of MSCs. But, the morbidity at the donor site and 
the complexity in obtaining sufficient amounts of tissue to extract 
MSCs still remains barriers for their clinical application.[4]
Periosteum has been tapped and recognized as a reservoir 
of clinically useful stem cells and progenitor cells. As periosteal 
Figure 2: Why periosteum should be harnessed for periodontal 
regeneration??
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cells possess robust potential to differentiate into osteoblasts, 
fibroblasts, chondroblasts, adipocytes and skeletal myocytes,[13] 
periosteum can offer a unique cell source for periodontal tissue 
engineering. In addition, periosteum can be harvested from 
many convenient sites to extract MSCs, such as sites adjacent to 
surgery. Regarding the donor site, it is simpler in the dental set-
up to harvest periosteum as compared to more widely used bone 
marrow-derived MSC (bMSCs), because dentists often access 
the mandibular periosteum during routine oral and periodontal 
surgeries. Many researches have reported periosteum-derived 
stem cells (PDCs) to be as good as, if not superior to bMSCs 
regarding healing and regeneration of bone.[35-37]
The use of PDCs for periodontal tissue regeneration is 
still in its infancy. Studies using PDCs with different scaffolds 
have shown considerable bone formation in a variety of bone 
defects.[35,38] One study compared the PDCs with the bMSCs 
(maxillary tuberosity) and found that both the cell types 
depicted similar phenotypes and generated bone upon ectopic 
transplantation in-vivo.[39] The collection quantity of PDCs 
required for tissue regeneration is yet to be determined. Still the 
PDCs are under continuous research.
With the advancements in tissue engineering, Mizuno et al. 
illustrated a technique to regenerate periodontal defects using 
autologous membranous cultured periosteum (CP) or human 
CP (HCP) sheets. They reported considerable regeneration 
of the bone defects. Regarding the technique, a prior surgery 
is required before actual regenerative surgery to harvest a 
piece of periosteum (usually from the posterior mandibular 
body). The periosteum specimen is then placed directly onto 
a culture dish in a pre-defined culture medium: 10% foetal 
bovine serum, 25 mg ascorbic acid, antibiotics (penicillin 
[100 IU/ml], and streptomycin [100 mg/ml]), and an antifungal 
agent (amphotericin-B [250 ng/ml]) and is incubated at 37°C; 
10% CO2. Culture medium has to be changed every 2-3 days. The 
periosteum samples are incubated until the cells form a sheet-
like structure (4 weeks approximately).[40] Several reports have 
showed the efficacy of HCP sheets in the treatment of periodontal 
intrabony defects. All the cases showed significant improvements 
in clinical and radiographic parameters of the defects.[32,41-43]
One of the distinctive features of this technique is that the 
cell scaffold is autologous which eliminates the risk of host-
immune responses to more commonly used exogenous scaffolds 
(polyglycolic acid or polylactic acid) often leading to graft 
rejection. Periosteal cells, during the formation of CP produce 
extracellular matrix that acts as a natural scaffold. Another 
advantage is the presence of stem cells and progenitor cells in 
CP. So, having a membranous structure with robust regenerative 
potential owing to the presence of stem cells and progenitor 
cells serves two purposes in regenerative therapy, enhancing the 
therapeutic efficiency. Moreover, dispersion cell cultures from 
periosteum require exogenous growth factors to attain a robust 
regenerative capacity. These exogenous factors are not needed 
with CP to uphold the regenerative potential of cells. Further 
research (including histologic evaluations) is required to precisely 
understand the role of CP in periodontal regeneration.[32]
Conclusion
To summarize, the periosteum has desired stem cells and 
progenitor cells, high vasculo-proliferative, and neuro-trophic 
activities, therefore, the regenerative potential of periosteum 
is enormous. Various surgical and/or tissue engineering 
approaches have been proposed to exploit this capability. PDCs 
are under continuous research using different types of scaffolds, 
in an attempt to regenerate periodontium. In addition, the 
designing of CP has become a dynamic research field in the 
past 6-7 years. Further research is required, using or combining 
a variety of techniques to ensure development in clinical usage 
of periosteum, and documentation of protocols is the key to 
success.
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